Cart
Free US shipping over $10
Proud to be B-Corp

Pediatric Psychopharmacology for Primary Care Clinicians Editor-in-chief Mark A. Riddle

Pediatric Psychopharmacology for Primary Care Clinicians By Editor-in-chief Mark A. Riddle

Pediatric Psychopharmacology for Primary Care Clinicians by Editor-in-chief Mark A. Riddle


$6.73
Condition - Good
Only 1 left

Summary

Provides a game-changing new approach in managing the complicated issues surrounding prescribing and monitoring psychopharmacological medications in children and teens. The new concept involves creating different levels of drugs. The compact reference book will be accompanied by a digital tool allowing physicians to quickly access information on specific conditions and medications.

Faster Shipping

Get this product faster from our US warehouse

Pediatric Psychopharmacology for Primary Care Clinicians Summary

Pediatric Psychopharmacology for Primary Care Clinicians by Editor-in-chief Mark A. Riddle

This innovative new resource provides a game-changing new approach in managing the complicated issues surrounding prescribing and monitoring psychopharmacological medications in children and teens.

The new concept involves creating different levels of drugs. Level 1 drugs can be confidently prescribed by primary care physicians, and the book gives guidance on starting, dosing, monitoring, and managing adverse reactions. Level 2 drugs are to be prescribed only by psychiatrists or those practicing paediatricians who have experience and comfort doing so. The book provides guidance for primary care physicians on monitoring specific Level 2 medications their patients may be taking.

It also provides resources on clinical assessment, preparation, and conceptual framework for prescribing; what to do if the medication isn't working; and managing multiple medications.

The compact reference book will be accompanied by a digital tool allowing the physician to quickly access information on specific conditions and medications.

Pediatric Psychopharmacology for Primary Care Clinicians Reviews

"This clear and well-organized volume provides an excellent and useful compendium of advice on the use of psychotropic medications in pediatric primary care. Building on strong work by the AAP over the past 15 to 20 years to develop clinical practice guidelines for primary care management of attention-deficit/hyperactivity disorder and the work of the AAP Task Force on Mental Health, this book offers clear guidance on when to use psychotropics, which to use, and what coexisting conditions and side effects the clinician should monitor." - James M. Perrin, MD, FAAP; John C. Robinson Chair in Pediatrics; Massachusetts General Hospital for Children; President (2014), American Academy of Pediatrics

About Editor-in-chief Mark A. Riddle

Mark A. Riddle, M.D. is Professor of Psychiatry and Pediatrics and former Director of the Division of Child and Adolescent Psychiatry at the Johns Hopkins University School of Medicine. His research, teaching and clinical practice focuses on pediatric psychopharmacology, particularly the efficacy and safety of psychotropic medications in children and adolescents. Dr. Riddle serves as a member of the National Institute of Child Health and Human Development-sponsored Data and Safety Monitoring Board for the Best Pharmaceuticals for Children Act. His clinical research and publications include pivotal studies of all of the major groups of medications prescribed to treat psychiatric disorders in children and adolescents.

Table of Contents

  • Introduction
  • Part 1-Conceptual Framework
  • Chapter 1-Conceptual Framework for Prescribing Psychotropic Medications
  • Background
  • Rationale for Conceptual Framework
  • Group 1 Medications for ADHD, Anxiety, and Depression
  • Specific Rationale
  • Group 2 Medications
  • Group 3 Medications
  • Part 2-Practical Guidance
  • Chapter 2-Assessment
  • Overview
  • General Clinical Guidance
  • Assessment
  • Formulation and Feedback
  • Chapter 3-Prescribing Medications: Getting Started
  • Part 3-Group 1 Medications for Specific Diagnoses: ADHD, Anxiety, and Depression
  • Chapter 4-Group 1 Medications for Attention-Deficit/Hyperactivity Disorder
  • General Guidance
  • Methylphenidate Preparations
  • Amphetamine Preparations
  • Guanfacine Preparations
  • Clonidine Preparations
  • Atomoxetine
  • Summary
  • Chapter 5-Group 1 Medications for Anxiety and Depression General Guidance
  • General Guidance
  • Group 1 Selective Serotonin Reuptake Inhibitors
  • Summary
  • Part 4-Group 2 (FDA-Approved Antipsychotics and Mood Stabilizers) and Group 3 (All Other) Medications
  • Chapter 6-Group 2 Medications: Antipsychotics and Mood Stabilizer
  • Rationale
  • Antipsychotics
  • The Mood Stabilizer Lithium
  • Summary
  • Chapter 7-Group 3 Medications
  • Other Antidepressants
  • Other Antipsychotics
  • Other Mood Stabilizers
  • Anxiolytics
  • Sleep Aids
  • Futures Considerations
  • Part 5-Advanced Topics
  • Chapter 8-What to Do When Treatment Is Not Successful
  • The Limits of Evidence-Based Treatments and Protocols
  • Reassess Diagnoses
  • Incomplete or Inaccurate Reports
  • Phenomenological or Nosologic Issues
  • Reassess Non-diagnostic Issues and Concerns
  • Reconsider Psychotherapy(ies) or Therapist
  • Reconsider Medication
  • When to Consider Group 2 Antipsychotics or Lithium
  • When to Consider Group 3 Medications Without FDA Approval for Use in Youth
  • When to Consider Drug Levels or Genetic Testing
  • When to Consider Consultation or a Second Opinion
  • When to Consider Referral for All or Part of the Patient's Ongoing Behavioral Care
  • Appendixes
  • Appendix A-Assessment and Symptom Monitoring Tools
  • Appendix B-Resources for Clinicians
  • Appendix C-Training Resources for Clinicians
  • Appendix D-Quality Ratings for Psychotherapies and Efficacy Data for Medications
  • Appendix E-Resources for Caregivers
  • Appendix F-Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Complete Criteria of Select Diagnosis
  • Index

Additional information

CIN1581102755G
9781581102758
1581102755
Pediatric Psychopharmacology for Primary Care Clinicians by Editor-in-chief Mark A. Riddle
Used - Good
Paperback
American Academy of Pediatrics
2015-11-30
225
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a used book - there is no escaping the fact it has been read by someone else and it will show signs of wear and previous use. Overall we expect it to be in good condition, but if you are not entirely satisfied please get in touch with us

Customer Reviews - Pediatric Psychopharmacology for Primary Care Clinicians